Vericel Announces FDA Acceptance of Biologics License Application for NexoBrid for the Treatment of Severe Thermal Burns
CAMBRIDGE, Mass., Sept. 16, 2020 (GLOBE NEWSWIRE) — Vericel Corporation (NASDAQ: VCEL) today announced that the U.S. Food and Drug […]